Effects of dexlansoprazole MR, a novel dual delayed release formulation of a proton pump inhibitor, on plasma gastrin levels in healthy subjects.
about
Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific RegionDelayed release dexlansoprazole in the treatment of GERD and erosive esophagitisDexlansoprazole in the treatment of esophagitis and gastroesophageal reflux disease.Pharmacokinetics and safety of dexlansoprazole MR in pediatric patients with symptomatic gastroesophageal reflux disease.Dexlansoprazole MR.Helicobacter pylori eradication does not influence gastroesophageal reflux disease: a prospective, parallel, randomized, open-label, controlled trial.
P2860
Effects of dexlansoprazole MR, a novel dual delayed release formulation of a proton pump inhibitor, on plasma gastrin levels in healthy subjects.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Effects of dexlansoprazole MR, ...... in levels in healthy subjects.
@en
Effects of dexlansoprazole MR, ...... in levels in healthy subjects.
@nl
type
label
Effects of dexlansoprazole MR, ...... in levels in healthy subjects.
@en
Effects of dexlansoprazole MR, ...... in levels in healthy subjects.
@nl
prefLabel
Effects of dexlansoprazole MR, ...... in levels in healthy subjects.
@en
Effects of dexlansoprazole MR, ...... in levels in healthy subjects.
@nl
P2093
P2860
P356
P1476
Effects of dexlansoprazole MR, ...... in levels in healthy subjects.
@en
P2093
Jingtao Wu
Stuart N Atkinson
Weijiang Zhang
P2860
P304
P356
10.1177/0091270008330155
P577
2009-04-01T00:00:00Z